Synthesis of hybrid drugs resulting from structure-based analysis of protein aggregation
Projektnummer
0052408
Zusammenfassung
In this propject, novel hybrid multifunctional compounds for preventing protein aggregation will be synthesized. Using Alzheimer diseases (AD) as the primary model, three existing A! binders which differ significantly, both in size and mode of action, will be used: monoclonal antibodies or recombinant fragements thereof (scFv) raised against various conformations of A!, D-peptides selected from phage display libraries, and aminopyrazoles specifically designed as beta-sheet ligands will be fused covalently to furnish hybrid compounds. By optimizing the length of flexible spacers, two di...
Projektinformationen
Status:
Beendet
Startdatum:
01.09.2007
Enddatum:
31.01.2012
Fördersumme:
706.000 €
Profilbereich:
Beendete Förderinitiativen
Förderinitiative:
Konformationelle Kontrolle biomolekularer Funktionen
Ausschreibung:
Konformationelle Kontrolle biomolekularer Funktionen